BRAIN Biotech AG Stock Deutsche Boerse AG
Equities
BNN
DE0005203947
Environmental Services & Equipment
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.69 EUR | -1.10% | -6.27% | -25.48% |
Sales 2024 * | 64.79M 69.27M | Sales 2025 * | 75.94M 81.2M | Capitalization | 62.92M 67.28M |
---|---|---|---|---|---|
Net income 2024 * | -5M -5.35M | Net income 2025 * | -2M -2.14M | EV / Sales 2024 * | 1.35 x |
Net Debt 2024 * | 24.4M 26.09M | Net Debt 2025 * | 22.75M 24.33M | EV / Sales 2025 * | 1.13 x |
P/E ratio 2024 * |
-17.2
x | P/E ratio 2025 * |
-21.2
x | Employees | 311 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 39.38% |
Latest transcript on BRAIN Biotech AG
1 day | -1.10% | ||
1 week | -6.27% | ||
Current month | -22.92% | ||
1 month | -24.01% | ||
3 months | -28.27% | ||
6 months | -29.40% | ||
Current year | -25.48% |
Managers | Title | Age | Since |
---|---|---|---|
Adriaan Moelker
CEO | Chief Executive Officer | 60 | 20-01-31 |
Director of Finance/CFO | 54 | 20-04-30 | |
Alexander Pelzer
CTO | Chief Tech/Sci/R&D Officer | 38 | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Majerus
CHM | Chairman | 63 | 19-03-06 |
Stephen Catling
BRD | Director/Board Member | 59 | 20-10-13 |
Director/Board Member | 70 | 20-10-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 2.69 | -1.10% | 0 |
24-04-25 | 2.72 | 0.00% | 70 |
24-04-24 | 2.72 | -4.56% | 0 |
24-04-23 | 2.85 | +4.01% | 100 |
24-04-22 | 2.74 | -4.53% | 50 |
Delayed Quote Deutsche Boerse AG, April 26, 2024 at 03:05 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.08% | 213M |
- Stock Market
- Equities
- BNN Stock
- BNN Stock